Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial.

McElroy SL, Guerdjikova A, Kotwal R, Welge JA, Nelson EB, Lake KA, Keck PE Jr, Hudson JI.

J Clin Psychiatry. 2007 Mar;68(3):390-8.

PMID:
17388708
2.

Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial.

McElroy SL, Kotwal R, Guerdjikova AI, Welge JA, Nelson EB, Lake KA, D'Alessio DA, Keck PE, Hudson JI.

J Clin Psychiatry. 2006 Dec;67(12):1897-906. Erratum in: J Clin Psychiatry. 2007 Jan;68(1):172.

PMID:
17194267
3.

Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial.

McElroy SL, Hudson JI, Malhotra S, Welge JA, Nelson EB, Keck PE Jr.

J Clin Psychiatry. 2003 Jul;64(7):807-13.

PMID:
12934982
4.

Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial.

McElroy SL, Kotwal R, Hudson JI, Nelson EB, Keck PE.

J Clin Psychiatry. 2004 Jan;65(1):50-6.

PMID:
14744168
5.

High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial.

Guerdjikova AI, McElroy SL, Kotwal R, Welge JA, Nelson E, Lake K, Alessio DD, Keck PE Jr, Hudson JI.

Hum Psychopharmacol. 2008 Jan;23(1):1-11.

PMID:
18058852
6.

A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder.

Arnold LM, McElroy SL, Hudson JI, Welge JA, Bennett AJ, Keck PE.

J Clin Psychiatry. 2002 Nov;63(11):1028-33.

PMID:
12444817
7.

Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial.

McElroy SL, Nelson EB, Welge JA, Kaehler L, Keck PE Jr.

J Clin Psychiatry. 2008 Mar;69(3):433-40.

PMID:
18251624
8.

A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.

Appolinario JC, Bacaltchuk J, Sichieri R, Claudino AM, Godoy-Matos A, Morgan C, Zanella MT, Coutinho W.

Arch Gen Psychiatry. 2003 Nov;60(11):1109-16.

PMID:
14609886
9.

Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia.

Martenyi F, Zavadenko NN, Jarkova NB, Yarosh AA, Soldatenkova VO, Bardenstein LM, Kozlova IA, Neznanov NG, Maslova OI, Petrukhin AS, Sukchotina NK, Zykov VP.

Eur Child Adolesc Psychiatry. 2010 Jan;19(1):57-66. doi: 10.1007/s00787-009-0042-7. Epub 2009 Jul 1.

PMID:
19568826
10.

Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial.

Gadde KM, Yonish GM, Wagner HR 2nd, Foust MS, Allison DB.

Int J Obes (Lond). 2006 Jul;30(7):1138-42. Epub 2006 Jan 17.

PMID:
16418753
11.

Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial.

Adler LA, Spencer T, Brown TE, Holdnack J, Saylor K, Schuh K, Trzepacz PT, Williams DW, Kelsey D.

J Clin Psychopharmacol. 2009 Feb;29(1):44-50. doi: 10.1097/JCP.0b013e318192e4a0.

PMID:
19142107
12.

Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.

Dell'Agnello G, Maschietto D, Bravaccio C, Calamoneri F, Masi G, Curatolo P, Besana D, Mancini F, Rossi A, Poole L, Escobar R, Zuddas A; LYCY Study Group.

Eur Neuropsychopharmacol. 2009 Nov;19(11):822-34. doi: 10.1016/j.euroneuro.2009.07.008. Epub 2009 Aug 28.

PMID:
19716683
13.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
14.

Memantine in the treatment of binge eating disorder: an open-label, prospective trial.

Brennan BP, Roberts JL, Fogarty KV, Reynolds KA, Jonas JM, Hudson JI.

Int J Eat Disord. 2008 Sep;41(6):520-6. doi: 10.1002/eat.20541.

PMID:
18433015
15.

An open trial of reboxetine in obese patients with binge eating disorder.

Silveira RO, Zanatto V, Appolinário JC, Kapczinski F.

Eat Weight Disord. 2005 Dec;10(4):e93-6.

PMID:
16682868
16.

Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.

Wang Y, Zheng Y, Du Y, Song DH, Shin YJ, Cho SC, Kim BN, Ahn DH, Marquez-Caraveo ME, Gao H, Williams DW, Levine LR.

Aust N Z J Psychiatry. 2007 Mar;41(3):222-30.

PMID:
17464703
17.

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.

Bangs ME, Hazell P, Danckaerts M, Hoare P, Coghill DR, Wehmeier PM, Williams DW, Moore RJ, Levine L; Atomoxetine ADHD/ODD Study Group.

Pediatrics. 2008 Feb;121(2):e314-20. doi: 10.1542/peds.2006-1880. Erratum in: Pediatrics.2008 Jul;122(1): 227.

PMID:
18245404
18.

Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder.

Claudino AM, de Oliveira IR, Appolinario JC, Cordás TA, Duchesne M, Sichieri R, Bacaltchuk J.

J Clin Psychiatry. 2007 Sep;68(9):1324-32.

PMID:
17915969
19.
20.

Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study.

Michelson D, Adler LA, Amsterdam JD, Dunner DL, Nierenberg AA, Reimherr FW, Schatzberg AF, Kelsey DK, Williams DW.

J Clin Psychiatry. 2007 Apr;68(4):582-7.

PMID:
17474814
Items per page

Supplemental Content

Write to the Help Desk